Report - IQWiG-Berichte – Nr. 698 Daratumumab (multiples Myelom) · 2020-05-19 · Daratumumab, Multiple Myeloma, Benefit Assessment, NCT02195479 . Dossierbewertung A18-66 Version 1.0 Daratumumab

Select PornographicDefamatoryIllegal/UnlawfulSpamOther Terms Of Service ViolationFile a copyright complaint

Please pass captcha verification before submit form